Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-19

Clinical Trial Update: Tafenoquine/Chloroquine DDI Study [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating potential drug-drug interactions between tafenoquine and chloroquine in malaria has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chloroquine (chloroquine)
  • Tafenoquine (tafenoquine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Malaria | Phase 1 | Status: COMPLETED